For many, work is a significant part of life.

Learn how to protect your joints in the workplace.

You can help Canadians live well with arthritis

Your donation helps support education resources, like information about surgery and joint replacement. These materials are free to access, and support from donors like you means we can continue to create and provide these valuable resources.

Donate Now

What is Arthritis?

Arthritis is a collection of conditions affecting joints and other tissues. It causes pain, restricts mobility and diminishes quality of life.

It's serious. 1 in 5 Canadians live every day with arthritis and there is no cure.

Learn More About Arthritis

How We Help

Research

Investments in research seek to understand the causes, realize innovations that improve quality of life and discover a cure.

Advocacy

Understanding needs of people affected by arthritis and identifying gaps that are important to champion for change.

Solutions

Providing patient-centric, evidenced-based information and resources to empower people affected by arthritis.

Thank you for giving.
Your generosity puts us closer to a world where people are free from the devastating effects that arthritis has on lives.

Arthritis. Give before it takes.

Donate Volunteer Participate

Live Better with Arthritis

Essential tips and guidance for moving through life with arthritis.

flourish logo

Visit flourish

Latest News

Jun 12

Advisory Council recommends Canada implement universal, single-payer public pharmacare Arthritis Society President and CEO Janet Yale responds: "On behalf of the 6 million Cdns living with arthritis, thanks to @DrEricHoskins for today’s Pharmacare report. As governments work together patients will need a seat at the table to help address the urgent needs of the uninsured... Public

May 27

B.C. expands use of biosimilars to offer coverage for more treatment options British Columbia is improving the sustainability of its PharmaCare program by expanding the use of biosimilars, which will create opportunities for new drug listings and boost existing coverage for patients. The Arthritis Society is gratified that our patient-focused recommendations to the... Public

May 27

B.C. arthritis, diabetes patients have 6 months to switch to cheaper ‘biosimilar’ drugs British Columbians on certain drugs for arthritis and diabetes will have six months to transition to equivalent less-costly drugs, as the province expands use of “biosimilars.” The move is expected to save $96 million over the first three years. Times Colonist

See All News